Biogenic Calcium Mineral-Chitosan Composite Nanofiber Dressing for Control of Traumatic Hemorrhage

IF 3.2 4区 医学 Q2 ENGINEERING, BIOMEDICAL
Pranabesh Kumar Sasmal, Shalini Dasgupta, Jerzy Kubacki, Samsamul Hoque, Samit Kumar Nandi, Abhijit Chanda, Pallab Datta
{"title":"Biogenic Calcium Mineral-Chitosan Composite Nanofiber Dressing for Control of Traumatic Hemorrhage","authors":"Pranabesh Kumar Sasmal,&nbsp;Shalini Dasgupta,&nbsp;Jerzy Kubacki,&nbsp;Samsamul Hoque,&nbsp;Samit Kumar Nandi,&nbsp;Abhijit Chanda,&nbsp;Pallab Datta","doi":"10.1002/jbm.b.35601","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Effective biomaterials for traumatic hemorrhage control remain an unmet clinical challenge, while several potential biomaterials, like oyster shell waste, are emerging as key ecological hazards. Hemostatic nanofiber dressing using biogenic calcium powders from <i>Magallana cuttackensis</i> is reported here. Extracted and treated powders were characterized by XRD, EDX, XPS, and Raman spectroscopy to confirm the presence of CaO and Ca(OH)<sub>2</sub> as the calcium phases. A chitosan-based nanofiber matrix, one of the most commonly used hemostatic dressing materials, was used as a control nanofiber (CNF) and integrated with shell waste calcium minerals (MSWNF). The hemolysis of CNF and MSWNF nanofibers was 5% ± 0.3% and 4% ± 0.2%, respectively. The in vitro clotting time (CT) under CNF and MSWNF nanofibers was 230 ± 11 s and 198 ± 4 s, which, along with other parameters—prothrombin times (27 ± 0.4 s and 22 ± 0.6 s) and plasma recalcification time (76 ± 4 s and 47 ± 1 s)—indicated enhancement in hemostasis performance by MSWNF over CNF. After in vivo evaluation in the rabbit incision model, the bleeding time of the control group (274 ± 6 s) was longer than CNF (97 ± 8 s) or MSWNF (75 ± 5 s). Blood oozing until hemostasis was 0.380 g, 0.354 g, and 0.121 g under control gauge, CNF, and MSWNF, respectively, demonstrating enhancement in hemostasis performance by MSWNF. Further, histopathological examination proved continued epithelialization and formation of capillaries, indicative of wound healing. The results provide promising evidence for a more effective biomaterial from biogenic oyster shell waste than commonly employed hemostatic dressing materials.</p>\n </div>","PeriodicalId":15269,"journal":{"name":"Journal of biomedical materials research. Part B, Applied biomaterials","volume":"113 6","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part B, Applied biomaterials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.b.35601","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Effective biomaterials for traumatic hemorrhage control remain an unmet clinical challenge, while several potential biomaterials, like oyster shell waste, are emerging as key ecological hazards. Hemostatic nanofiber dressing using biogenic calcium powders from Magallana cuttackensis is reported here. Extracted and treated powders were characterized by XRD, EDX, XPS, and Raman spectroscopy to confirm the presence of CaO and Ca(OH)2 as the calcium phases. A chitosan-based nanofiber matrix, one of the most commonly used hemostatic dressing materials, was used as a control nanofiber (CNF) and integrated with shell waste calcium minerals (MSWNF). The hemolysis of CNF and MSWNF nanofibers was 5% ± 0.3% and 4% ± 0.2%, respectively. The in vitro clotting time (CT) under CNF and MSWNF nanofibers was 230 ± 11 s and 198 ± 4 s, which, along with other parameters—prothrombin times (27 ± 0.4 s and 22 ± 0.6 s) and plasma recalcification time (76 ± 4 s and 47 ± 1 s)—indicated enhancement in hemostasis performance by MSWNF over CNF. After in vivo evaluation in the rabbit incision model, the bleeding time of the control group (274 ± 6 s) was longer than CNF (97 ± 8 s) or MSWNF (75 ± 5 s). Blood oozing until hemostasis was 0.380 g, 0.354 g, and 0.121 g under control gauge, CNF, and MSWNF, respectively, demonstrating enhancement in hemostasis performance by MSWNF. Further, histopathological examination proved continued epithelialization and formation of capillaries, indicative of wound healing. The results provide promising evidence for a more effective biomaterial from biogenic oyster shell waste than commonly employed hemostatic dressing materials.

生物钙矿物-壳聚糖复合纳米纤维敷料控制外伤性出血
有效的生物材料控制创伤性出血仍然是一个未满足的临床挑战,而一些潜在的生物材料,如牡蛎壳废料,正在成为关键的生态危害。本文报道了一种利用毛大麦草生物钙粉止血的纳米纤维敷料。采用XRD、EDX、XPS和拉曼光谱对提取和处理后的粉末进行了表征,证实了CaO和Ca(OH)2是钙相。采用壳聚糖基纳米纤维基质作为对照纳米纤维(CNF),与贝壳废钙矿物(MSWNF)结合,制备了一种最常用的止血敷料。CNF和MSWNF纳米纤维的溶血率分别为5%±0.3%和4%±0.2%。CNF和MSWNF纳米纤维作用下的体外凝血时间(CT)分别为230±11 s和198±4 s,与凝血酶原时间(27±0.4 s和22±0.6 s)和血浆再钙化时间(76±4 s和47±1 s)等参数一起,表明MSWNF对CNF的止血性能有增强作用。经兔切口模型体内评价,对照组出血时间(274±6 s)明显长于CNF(97±8 s)和MSWNF(75±5 s)。对照组、CNF组和MSWNF组止血前的渗血量分别为0.380 g、0.354 g和0.121 g,说明MSWNF对止血效果有增强作用。此外,组织病理学检查证实持续的上皮化和毛细血管的形成,表明伤口愈合。研究结果为从生物源牡蛎壳废物中提取比常用止血敷料更有效的生物材料提供了有希望的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.50
自引率
2.90%
发文量
199
审稿时长
12 months
期刊介绍: Journal of Biomedical Materials Research – Part B: Applied Biomaterials is a highly interdisciplinary peer-reviewed journal serving the needs of biomaterials professionals who design, develop, produce and apply biomaterials and medical devices. It has the common focus of biomaterials applied to the human body and covers all disciplines where medical devices are used. Papers are published on biomaterials related to medical device development and manufacture, degradation in the body, nano- and biomimetic- biomaterials interactions, mechanics of biomaterials, implant retrieval and analysis, tissue-biomaterial surface interactions, wound healing, infection, drug delivery, standards and regulation of devices, animal and pre-clinical studies of biomaterials and medical devices, and tissue-biopolymer-material combination products. Manuscripts are published in one of six formats: • original research reports • short research and development reports • scientific reviews • current concepts articles • special reports • editorials Journal of Biomedical Materials Research – Part B: Applied Biomaterials is an official journal of the Society for Biomaterials, Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Manuscripts from all countries are invited but must be in English. Authors are not required to be members of the affiliated Societies, but members of these societies are encouraged to submit their work to the journal for consideration.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信